Search Results - "Kudrnová, Z"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Incidence of proximal femur fractures in relation to seasons of the year and weather by Burget, F, Pleva, L, Kudrna, K, Kudrnová, Z

    “…The opinion that proximal femur fractures occur mainly in the winter season and are related to slippery surfaces prevails in both the lay and medical…”
    Get full text
    Journal Article
  2. 2

    GIST of pancreas by Krska, Z, Pesková, M, Povýsil, C, Horejs, J, Sedlácková, E, Kudrnová, Z

    Published in Prague medical report (2005)
    “…Authors present the case (from the year 2003) of a 38 years old patient, female with large tumor in the abdominal cavity. Preoperative differential diagnostic…”
    Get more information
    Journal Article
  3. 3

    Inflammatory response in patients undergoing hip surgery due to osteoarthrosis or different types of hip fractures by Sedlář, M., M.D, Kudrnová, Z., M.D, Trča, S., M.D, Mazoch, J., Ph.D, Malíková, I., M.D, Kvasnička, J., M.D, Krška, Z., M.D., Ph.D, Zeman, M., M.D., Ph.D, Linhart, A., M.D., Ph.D

    Published in Osteoarthritis and cartilage (01-01-2008)
    “…Summary Objective Hip surgery represents a major intervention associated with significant inflammatory response. The objective of our study was to compare…”
    Get full text
    Journal Article
  4. 4

    Prophylaxis of venous thromboembolic disease in patients after the proximal femoral surgery by Kudrnová, Z

    Published in Časopis lékařů českých (2005)
    “…Patients undergoing elective hip replacement and surgery for hip fracture are at increased risk of venous thromboembolic disease, a potentially preventable…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Comparison of various types of pharmacological prevention of lower extremities deep vein thrombosis in patients with proximal femoral fractures by Trca, S, Krska, Z, Sedlár, M, Kudrnová, Z, Dohnalová, A

    Published in Rozhledy v chirurgii (01-05-2007)
    “…Adminstration of coagulation-active substances is one of the options to prevent thromboemboembolic disease (TED), including deep vein thrombosis and systemic…”
    Get more information
    Journal Article